The stock of Doximity Inc (NYSE:DOCS) last traded at $79.23, up 35.99% from the previous session.
DOCS stock price is now 43.07% away from the 50-day moving average and 99.75% away from the 200-day moving average. The market capitalization of the company currently stands at $14.87B.
With the price target enhanced from $31 to $78, Piper Sandler Upgraded its rating from Neutral to Overweight for Doximity Inc (NYSE: DOCS). On February 07, 2025, Leerink Partners Upgraded its previous ‘Market Perform’ rating to ‘Outperform’ on the stock increasing its target price from $60 to quote $90, while ‘Stephens’ rates the stock as ‘Equal-Weight’
In other news, Cabral Timothy S, Director sold 20,000 shares of the company’s stock on Feb 03 ’25. The stock was sold for $1,152,498 at an average price of $57.62. Upon completion of the transaction, the Director now directly owns 6,360 shares in the company, valued at $0.5 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 03 ’25, Director TIMOTHY CABRAL bought 20,000 shares of the business’s stock. A total of $1,152,497 was incurred on buying the stock at an average price of $57.62. A total of 32.15% of the company’s stock is owned by insiders.
During the past 12 months, Doximity Inc has had a low of $22.96 and a high of $61.75. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 8.67, and a quick ratio of 8.67. According to the stock market information, the enterprise value for the company is $10084594688, which is based on a 79.09 price-to-earnings ratio, a 4.22 price-to-earnings-growth ratio, and a beta of 1.39. The fifty day moving average price for DOCS is $55.3784 and a two-hundred day moving average price translates $39.66545 for the stock.
The latest earnings results from Doximity Inc (NYSE: DOCS) was released for 2024-09-30. The net profit margin was 36.60% and return on equity was 21.24% for DOCS. The company reported revenue of $136.83 million for the quarter, compared to $113.61 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 20.44 percent. For the current quarter, analysts expect DOCS to generate $134.03M in revenue.
